Full Text View
Tabular View
No Study Results Posted
Related Studies
Pazopanib in Treating Patients With Stage IV or Recurrent Nasopharyngeal Cancer
This study is currently recruiting participants.
Study NCT00454142   Information provided by National Cancer Institute (NCI)
First Received: March 27, 2007   Last Updated: June 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Head and Neck Cancer
Additional conditions recognized in this trial
Head and Neck Neoplasms
Nasopharyngeal Neoplasms
More general conditions related to this trial
Nasopharyngeal Diseases
Neoplasms
Neoplasms by Site
Otorhinolaryngologic Diseases
Otorhinolaryngologic Neoplasms
Pharyngeal Diseases
Pharyngeal Neoplasms
Stomatognathic Diseases
Interventions listed in this trial
pazopanib hydrochloride
pharmacological study
computed tomography
Sponsors listed in this trial
Cancer Therapeutics Research Group
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services